- https://10xhire.io/employer/what-we-test/
-
- FDA approved for use in males with hypogonadotropic hypogonadism and pediatric patients with cryptorchidism. Despite these effects, neither treatment led to significant changes in semen parameters.
-
Joined on
2026-04-02
There are no packages yet.
For more information on the package registry, see the documentation.